| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/11/2013 | CN103432317A Medicament for treating headache and preparation method thereof |
| 12/11/2013 | CN103432283A Application of physalis pubescens in preparation of medicaments or health care products for treating or preventing tumor and neurodegenerative diseases |
| 12/11/2013 | CN103432281A Compound flos daturae and asarum body resistance strengthening capsules and preparation method thereof |
| 12/11/2013 | CN103432274A Medicament for treating migraine and preparation method thereof |
| 12/11/2013 | CN103432271A Foot bath health care product |
| 12/11/2013 | CN103432229A Pharmaceutical composition for preventing and treating senile dementia |
| 12/11/2013 | CN103432212A Traditional Chinese medicine effective part composition for treating sciatica and preparation method thereof |
| 12/11/2013 | CN103432208A Medicinal composition containing cordyceps sinensis |
| 12/11/2013 | CN103432204A Traditional Chinese medicine effective part composition for treating schizophrenia and preparation method thereof |
| 12/11/2013 | CN103432200A Medicament for treating cardiovascular and orthopedic diseases |
| 12/11/2013 | CN103432184A Application of great burdock fruit extract in drug production or foods |
| 12/11/2013 | CN103432144A Application of withanolide compound in preparation of drug or healthcare product for treating or preventing tumors and neurodegenerative diseases |
| 12/11/2013 | CN103432132A Pridinol mesylate diclofenac sodium injection and preparation method thereof |
| 12/11/2013 | CN103432118A Application of andrographolide derivatives in preparing medicaments for preventing and treating neurodegenerative diseases |
| 12/11/2013 | CN103432110A Application of salvianolic acid A freeze-dried injection in preparing drug for rescuing ischemic penumbra |
| 12/11/2013 | CN103432107A Tapentadol hydrochloride paracetamol orally disintegrating tablet and preparation method thereof |
| 12/11/2013 | CN103432104A Transdermal patch containing pramipexole |
| 12/11/2013 | CN103432093A Pridinol methanesulfonate matrix sustained-release tablet and preparation method thereof |
| 12/11/2013 | CN103432090A Cyclovirobuxine D sublingual tablet as well as preparation method and application thereof |
| 12/11/2013 | CN103432070A 左乙拉西坦注射液和制法 Levetiracetam injection and production method |
| 12/11/2013 | CN103432068A Pridinol mesylate injection and preparation method thereof |
| 12/11/2013 | CN103432029A Composition and tissue employing same |
| 12/11/2013 | CN103431697A Blood pressure-reducing and eyesight-improving health-care medicine pillow inner and preparation method thereof |
| 12/11/2013 | CN103431382A Sea cucumber cream health-care food capable of nourishing kidney and tonifying yin |
| 12/11/2013 | CN103005466B Application for drone pupae polypeptide extract |
| 12/11/2013 | CN102988522B Preparation method and application of naodesheng tablets |
| 12/11/2013 | CN102973900B Traditional Chinese medicine composition for treating anxiety neurosis |
| 12/11/2013 | CN102973768B Qianzheng paste for treating acute and chronic facial paralysis |
| 12/11/2013 | CN102846664B Deproteinised calf blood extract, preparation method and application thereof |
| 12/11/2013 | CN102784278B Method for preparing traditional Chinese medicine for treating insomnia caused by parasitic malnutrition |
| 12/11/2013 | CN102772601B External medicine for treating facial paralysis and preparation method thereof |
| 12/11/2013 | CN102764418B Medicine for treating anaudia and aphasia caused by apoplexy |
| 12/11/2013 | CN102755592B Traditional Chinese medicine preparation for treating schizophrenia |
| 12/11/2013 | CN102702052B Novel diamine-containing farnesyl thiosalicylic acid derivative and preparation method and medicinal application thereof |
| 12/11/2013 | CN102600238B Traditional Chinese medicine used for treating ischialgia |
| 12/11/2013 | CN102533434B Preparation method and application of euphorbia sororia fruit grease and derivative |
| 12/11/2013 | CN102526042B Stable liquid medicinal composition |
| 12/11/2013 | CN102488803B Preparation method for superfine bupleurum powder under normal temperature |
| 12/11/2013 | CN102406850B Traditional Chinese preparation for treating senile dementia |
| 12/11/2013 | CN102361645B Composition for prevention or treatment of insomnia |
| 12/11/2013 | CN102232075B Amino pyrazole compound |
| 12/11/2013 | CN102159563B Novel substituted sulfamide derivatives |
| 12/11/2013 | CN102153538B Benzocyclodirivative |
| 12/11/2013 | CN102133242B Tuckahoe extract and preparation method thereof |
| 12/11/2013 | CN101861319B Benzazepinone compound |
| 12/11/2013 | CN101622255B Spirocyclic cyclohexane derivatives |
| 12/11/2013 | CN101534648B Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 12/10/2013 | US8604083 Method for the treatment of metabolic disorders |
| 12/10/2013 | US8604076 Method for producing a pharmaceutical composition comprising rotigotine |
| 12/10/2013 | US8604070 Use of inhibitors of the renin-angiotensin system |
| 12/10/2013 | US8604049 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| 12/10/2013 | US8604039 Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 12/10/2013 | US8604033 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors |
| 12/10/2013 | US8604021 Substituted arylamine compounds and methods of treatment |
| 12/10/2013 | US8604011 Therapy for treatment of chronic degenerative brain diseases and nervous system injury |
| 12/10/2013 | US8603984 Methods for controlling pain in canines using a transdermal solution of fentanyl |
| 12/10/2013 | US8603983 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| 12/10/2013 | US8603814 Method of inhibiting nonsense-mediated mRNA decay |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | CA2736615C Method for classifying and treating physiologic brain imbalances using quantitative eeg |
| 12/10/2013 | CA2599511C 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 12/10/2013 | CA2583779C Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to m0dulation of the dopamine d3 receptor |
| 12/10/2013 | CA2566092C Crystalline forms of duloxetine free base |
| 12/10/2013 | CA2489084C A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 12/10/2013 | CA2476984C Lactoferrin as an agent for enhancing action of an opioid |
| 12/10/2013 | CA2471947C Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/10/2013 | CA2464700C Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/05/2013 | WO2013181472A1 Treatment of stress-related disorders |
| 12/05/2013 | WO2013181454A1 Plant lectins as carriers of associated drug substances into animal and human cells |
| 12/05/2013 | WO2013181451A1 Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate |
| 12/05/2013 | WO2013181296A2 Compositions and methods for managing weight |
| 12/05/2013 | WO2013181228A1 Dna modifying fusion proteins and methods of use thereof |
| 12/05/2013 | WO2013181135A1 Quinazoline derivatives, compositions, and uses related thereto |
| 12/05/2013 | WO2013180271A1 Prodrug of fluorine-containing amino acid |
| 12/05/2013 | WO2013180265A1 Heterocyclic compound |
| 12/05/2013 | WO2013180240A1 Medicine comprising combination of general anesthetic drug and hydrogen |
| 12/05/2013 | WO2013180238A1 Therapeutic agent or prophylactic agent for dementia |
| 12/05/2013 | WO2013180114A1 Agent for treating and agent for preventing dementia |
| 12/05/2013 | WO2013180066A1 Pyridine derivative having inhibitory effect on tlr |
| 12/05/2013 | WO2013179910A1 Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug |
| 12/05/2013 | WO2013179309A1 Novel compounds as memory enhancers |
| 12/05/2013 | WO2013179153A1 Compositions and methods for treatment of neurological degenerative disorders and neurological diseases |
| 12/05/2013 | WO2013179049A1 Spiro derivatives as voltage - gated sodium channel modulators |
| 12/05/2013 | WO2013179024A1 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases |
| 12/05/2013 | WO2013178880A1 Composition for preventing headaches |
| 12/05/2013 | WO2013178846A1 Pharmaceutical composition comprising diacetylmorphine and naloxone for oral administration |
| 12/05/2013 | WO2013178569A1 Pyrrolidino heterocycles |
| 12/05/2013 | WO2013178322A1 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases |
| 12/05/2013 | WO2013177922A1 Polypeptide for treating alzheimer's disease and genetic vaccine |
| 12/05/2013 | WO2013153155A3 The use of mirna particles and mirna antagomir for diagnostics, prevention and treatment of multiple sclerosis |
| 12/05/2013 | WO2013150542A3 A transdermal patch for treatment of dementia or alzheimer type dementia |
| 12/05/2013 | WO2013150406A3 Siphonochilone and related compounds and uses thereof |
| 12/05/2013 | WO2013130826A3 Igg stimulated remyelination of peripheral nerves |
| 12/05/2013 | US20130324759 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 12/05/2013 | US20130324572 Remedy for psychoneurotic diseases |
| 12/05/2013 | CA2875348A1 Chemical suppressors of neurotoxicity in synucleinopathic diseases |